Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Nova Ltd — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.43 (market cap $6.04B), while Nova Ltd trades at $361.15 (market cap $11.28B). The key difference: Nova Ltd is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Nova Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Nova Ltd for 5 Days on average.
| IOVA | NVMI | |
|---|---|---|
Market Cap | $6.04B | $11.28B |
Volume | 14,805,993 | 394,997 |
Sector | Health | Technology |
52-Week High | $14.82 | $605.65 |
52-Week Low | $1.81 | $275.78 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $5.97B | $11.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
